Medicina
Saila
University of Bristol
Brístol, Reino UnidoUniversity of Bristol-ko ikertzaileekin lankidetzan egindako argitalpenak (23)
2021
-
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
The Lancet Respiratory Medicine, Vol. 9, Núm. 12, pp. 1407-1418
-
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
Human Genetics and Genomics Advances, Vol. 2, Núm. 3
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
-
Oral Bisphosphonate Use and All-Cause Mortality in Patients With Moderate–Severe (Grade 3B-5D) Chronic Kidney Disease: A Population-Based Cohort Study
Journal of Bone and Mineral Research, Vol. 35, Núm. 5, pp. 894-900
2019
-
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party
Cancer, Vol. 125, Núm. 1, pp. 90-98
-
Equalization of four cardiovascular risk algorithms after systematic recalibration: Individual-participant meta-analysis of 86 prospective studies
European Heart Journal, Vol. 40, Núm. 7, pp. 621-631
-
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)
Nature Communications
-
Shared heritability and functional enrichment across six solid cancers
Nature Communications, Vol. 10, Núm. 1
2018
-
Access to kidney transplantation in European adults aged 75–84 years and related outcomes: an analysis of the European Renal Association–European Dialysis and Transplant Association Registry
Transplant International, Vol. 31, Núm. 5, pp. 540-553
-
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party
British Journal of Haematology, Vol. 181, Núm. 1, pp. 86-96
-
Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations
Scientific Reports, Vol. 8, Núm. 1
-
Clinical use of intracoronary imaging. Part 1: Guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions
EuroIntervention, Vol. 14, Núm. 6, pp. 656-677
-
Clinical use of intracoronary imaging. Part 1: Guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions
European Heart Journal, Vol. 39, Núm. 35, pp. 3281-3300
-
Kidney transplant outcomes from older deceased donors: a paired kidney analysis by the European Renal Association–European Dialysis and Transplant Association Registry
Transplant International, Vol. 31, Núm. 7, pp. 708-719
-
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
The Lancet, Vol. 391, Núm. 10129, pp. 1513-1523
2016
-
The changing trends and outcomes in renal replacement therapy: Data from the ERA-EDTA Registry
Nephrology Dialysis Transplantation, Vol. 31, Núm. 5, pp. 831-841
2015
-
Renal replacement therapy in Europe: A summary of the 2012 ERA-EDTA Registry Annual Report
Clinical Kidney Journal, Vol. 8, Núm. 3, pp. 248-261
2014
-
Glycated hemoglobin measurement and prediction of cardiovascular disease
JAMA - Journal of the American Medical Association, Vol. 311, Núm. 12, pp. 1225-1233
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2011
-
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies
The Lancet, Vol. 377, Núm. 9771, pp. 1085-1095